Published in JAMA Oncology · View the paper (DOI)
Researchers investigated the association between convalescent plasma treatment and mortality in hospitalized adults with hematologic cancers and COVID-19. The study found that convalescent plasma therapy was associated with improved survival rates among these patient groups.
Coverage from 3 institutions